Stock listing
LSE:POLB Poolbeg Pharma PLC Share Price
Home listing (LSE) of Poolbeg Pharma PLC
Follow Poolbeg Pharma PLC into a list and get an email when it puts out news.
Share price · LSE:POLB
6.50p GBX (pence) 0.00 (0.0%)
Close on Oct 30, 2026
- Day range
- 6.30p – 6.60p GBX (pence)Oct 30, 2026
- Volume
- 403,346 sharesOct 30, 2026
- Market cap
- £49.62M GBPAt the close on Oct 30, 2026 · price × 763.4M shares outstanding
- 52-week range
- 3.30p – 9.30p GBX (pence)Lowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- £182,910 GBPMedian day 1.53M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:POLB · Home | 6.50p GBX (pence) | 0.00 (0.0%) | 403,346 | 6.50p | 6.60p | 6.30p | 6.50p | Close on Oct 30, 2026 |
| Frankfurt:7JN | €0.067 EUR | -0.002 (-2.2%) | — | €0.067 | €0.067 | €0.067 | €0.068 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · LSE:POLB · GBX (pence), adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 6.50p | 0.00 | 0.0% | 6.50p | 6.60p | 6.30p | 403,346 | |
| 6.50p | -0.15 | -2.3% | 6.65p | 6.695p | 6.332p | 304,561 | |
| 6.65p | 0.00 | 0.0% | 6.65p | 6.697p | 6.50p | 460,013 | |
| 6.65p | -0.10 | -1.5% | 6.75p | 6.897p | 6.60p | 778,385 | |
| 6.75p | +0.09 | +1.4% | 6.45p | 6.897p | 6.335p | 1,528,062 | |
| 6.66p | +0.16 | +2.5% | 6.50p | 6.66p | 6.315p | 287,905 | |
| 6.50p | +0.25 | +4.0% | 6.25p | 6.70p | 6.10p | 1,865,446 | |
| 6.25p | 0.00 | 0.0% | 6.25p | 6.40p | 5.894p | 2,248,702 | |
| 6.25p | 0.00 | 0.0% | 6.25p | 6.40p | 6.10p | 584,172 | |
| 6.25p | -0.05 | -0.8% | 6.30p | 6.50p | 6.10p | 247,094 | |
| 6.30p | -0.30 | -4.5% | 6.40p | 6.50p | 6.10p | 929,307 | |
| 6.60p | +0.20 | +3.1% | 6.35p | 6.60p | 6.20p | 643,308 | |
| 6.40p | -0.10 | -1.5% | 6.50p | 6.60p | 6.30p | 1,580,972 | |
| 6.50p | -0.40 | -5.8% | 6.90p | 6.90p | 6.30p | 2,972,319 | |
| 6.90p | 0.00 | 0.0% | 6.90p | 7.00p | 6.80p | 412,852 | |
| 6.90p | 0.00 | 0.0% | 6.90p | 7.00p | 6.833p | 583,157 | |
| 6.90p | 0.00 | 0.0% | 6.90p | 7.00p | 6.80p | 489,113 | |
| 6.90p | -0.30 | -4.2% | 7.15p | 7.21p | 6.80p | 3,245,625 | |
| 7.20p | +0.20 | +2.9% | 7.10p | 7.30p | 6.90p | 831,462 | |
| 7.00p | -0.18 | -2.5% | 7.10p | 7.30p | 6.90p | 594,920 | |
| 7.18p | -0.17 | -2.3% | 7.35p | 7.50p | 6.90p | 1,127,024 | |
| 7.35p | -0.05 | -0.7% | 7.35p | 7.50p | 7.20p | 1,029,441 | |
| 7.40p | 0.00 | 0.0% | 7.35p | 7.50p | 7.20p | 554,887 | |
| 7.40p | +0.05 | +0.7% | 7.35p | 7.50p | 7.20p | 545,125 | |
| 7.35p | +0.25 | +3.5% | 7.10p | 7.60p | 7.052p | 6,680,306 | |
| 7.10p | -0.80 | -10.1% | 7.85p | 8.00p | 6.56p | 15,336,310 | |
| 7.90p | -1.15 | -12.7% | 9.15p | 9.30p | 7.50p | 10,213,737 | |
| 9.05p | +0.05 | +0.6% | 9.00p | 9.30p | 8.80p | 1,511,750 | |
| 9.00p | 0.00 | 0.0% | 9.00p | 9.20p | 8.802p | 647,637 | |
| 9.00p | +0.15 | +1.7% | 8.85p | 9.20p | 8.70p | 2,766,692 | |
| 8.85p | -0.20 | -2.2% | 9.05p | 9.30p | 8.70p | 528,905 | |
| 9.05p | +0.10 | +1.1% | 8.95p | 9.30p | 8.80p | 1,241,303 | |
| 8.95p | +0.25 | +2.9% | 8.70p | 9.14p | 8.60p | 2,953,490 | |
| 8.70p | +0.30 | +3.6% | 8.40p | 8.80p | 8.30p | 720,027 | |
| 8.40p | +0.10 | +1.2% | 8.35p | 8.50p | 8.30p | 849,412 | |
| 8.30p | -0.10 | -1.2% | 8.40p | 8.55p | 8.30p | 2,518,226 | |
| 8.40p | +0.05 | +0.6% | 8.35p | 8.50p | 8.30p | 1,298,629 | |
| 8.35p | -0.05 | -0.6% | 8.40p | 8.50p | 8.30p | 331,576 | |
| 8.40p | +0.10 | +1.2% | 8.35p | 8.50p | 8.30p | 1,684,536 | |
| 8.30p | +0.05 | +0.6% | 8.25p | 8.44p | 8.20p | 1,407,519 | |
| 8.25p | -0.33 | -3.8% | 8.40p | 8.50p | 8.20p | 1,473,549 | |
| 8.58p | +0.34 | +4.1% | 8.25p | 8.58p | 8.20p | 4,492,676 | |
| 8.24p | -0.11 | -1.3% | 8.35p | 8.50p | 8.20p | 1,126,084 | |
| 8.35p | -0.25 | -2.9% | 8.45p | 8.80p | 8.30p | 2,166,547 | |
| 8.60p | +0.20 | +2.4% | 8.45p | 8.60p | 8.30p | 2,290,227 | |
| 8.40p | -0.20 | -2.3% | 8.65p | 9.00p | 8.40p | 3,210,258 | |
| 8.60p | 0.00 | 0.0% | 8.60p | 8.80p | 8.40p | 1,816,142 | |
| 8.60p | +0.10 | +1.2% | 8.50p | 9.00p | 8.40p | 4,910,295 | |
| 8.50p | -0.30 | -3.4% | 8.80p | 9.00p | 8.40p | 3,090,204 | |
| 8.80p | -0.20 | -2.2% | 8.95p | 9.20p | 8.70p | 1,909,752 | |
| 9.00p | +0.35 | +4.0% | 8.65p | 9.20p | 8.50p | 2,656,061 | |
| 8.65p | -0.15 | -1.7% | 8.65p | 8.80p | 8.50p | 1,532,319 | |
| 8.80p | +0.10 | +1.1% | 8.60p | 9.00p | 8.50p | 2,166,127 | |
| 8.70p | +0.20 | +2.4% | 8.50p | 8.80p | 8.30p | 1,101,584 | |
| 8.50p | -0.20 | -2.3% | 8.75p | 9.00p | 8.32p | 1,707,574 | |
| 8.70p | +0.05 | +0.6% | 8.65p | 9.00p | 8.50p | 3,810,014 | |
| 8.65p | +0.45 | +5.5% | 8.20p | 9.00p | 8.00p | 7,183,425 | |
| 8.20p | -0.16 | -1.9% | 8.30p | 8.40p | 8.00p | 2,011,724 | |
| 8.36p | +0.06 | +0.7% | 8.15p | 8.40p | 8.00p | 4,422,562 | |
| 8.30p | +0.32 | +4.0% | 7.85p | 8.30p | 7.70p | 2,630,371 | |
| 7.98p | -0.32 | -3.9% | 8.00p | 8.60p | 7.70p | 6,639,667 | |
| 8.30p | +1.10 | +15.3% | 7.30p | 8.30p | 7.30p | 6,165,213 | |
| 7.20p | +0.30 | +4.3% | 6.75p | 7.30p | 6.60p | 4,499,117 | |
| 6.90p | +0.20 | +3.0% | 6.65p | 6.989p | 6.60p | 1,370,237 | |
| 6.70p | +0.30 | +4.7% | 6.30p | 6.80p | 6.10p | 2,046,659 | |
| 6.40p | +0.10 | +1.6% | 6.30p | 6.50p | 6.10p | 1,423,368 |
- Ticker
- LSE:POLB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- GBX
What changed lately
Latest news release · Oct 6, 2026
POLB001 CRS Patent Granted in South Korea
Latest earnings call · Sep 24, 2026
Poolbeg Pharma (LSE:POLB) — Company Presentation
Replay and transcript
Latest deck · Oct 28, 2026
Investor Presentation (October 2026)
Investor deck · 24 slides
Calls
Replays
Poolbeg Pharma (LSE:POLB) — Company Presentation
Thu, Sep 24, 2026 · 9:00 AM ET
Watch TranscriptPoolbeg Pharma (LSE:POLB) Q4 2025 Earnings Call
Tue, Apr 28, 2026 · 12:00 PM ET
Watch TranscriptPoolbeg Pharma (LSE:POLB) — POLB 001 Phase 2a Trial Update
Mon, Sep 29, 2025 · 12:00 PM ET
Watch Transcript
Latest news
POLB001 CRS Patent Granted in South Korea
Oct 6, 2026
Closed 7.20p (+2.9%) on Oct 6, 2026
Interim Results for the six months to 30 June 2026
Sep 29, 2026
Closed 7.40p (+0.7%) on Sep 29, 2026
POLB 001 TOPICAL trial recruitment update
Sep 28, 2026
Closed 7.35p (+3.5%) on Sep 28, 2026
Interim data from POLB 001 TOPICAL clinical trial
Sep 24, 2026
Closed 7.90p (-12.7%) on Sep 24, 2026
Key Conference Participation in September 2026
Sep 3, 2026
Closed 8.58p (+4.1%) on Sep 3, 2026
Notification of major holdings
Jul 23, 2026
Closed 6.15p (+0.8%) on Jul 23, 2026
Notice of Allowance for POLB 001 patent in Israel
Jul 21, 2026
Closed 6.20p (+0.6%) on Jul 21, 2026
Placing to raise £3.5 million
Jul 14, 2026
Closed 6.05p (-13.6%) on Jul 14, 2026
First patient dosed in POLB 001 TOPICAL trial
Jul 13, 2026
Closed 7.00p (0.0%) on Jul 13, 2026
POLB 001 patent granted in South Africa
Jun 30, 2026
Closed 6.85p (+1.5%) on Jun 30, 2026
Financings
Private placement of new ordinary shares
Sep 29, 2026 · US$4.63M
Closed: £3.5M raised · GBX 6 a share · OAK Securities
Dealers: OAK Securities (lead)
Buyers: Cathal Friel (£250,000 subscription)
Insiders: Executive Chair Cathal Friel subscribed a further £250,000
Use of proceeds: Fund the POLB 001 TOPICAL trial and the oral GLP-1 proof-of-concept trial to completion; strengthen partnering position
Decks
Investor Presentation (October 2026)
Investor deck · 24 slides · Oct 28, 2026
Investor Presentation (October 2026)
Investor deck · 38 slides · October 2026
Q4 2025 Earnings Presentation
Earnings · 35 slides · Apr 28, 2026
Investor Presentation (June 2025)
Investor deck · 34 slides · June 2025
Poolbeg Pharma PLC on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 144 in all · newest Oct 6, 2026 · oldest 2021
- Calls
- 12 calls with a replay · 12 with a transcript · latest Sep 24, 2026
- Decks
- 8 decks · latest Oct 28, 2026
Where Poolbeg Pharma PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:POLB · Home listing · This page | LSE | United Kingdom | GBX |
| OTC:POLBF | OTC | United States | USD |
| Frankfurt:7JN | Frankfurt | Germany | EUR |
| Stuttgart:7JN | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Poolbeg Pharma PLC.